Welcome to LookChem.com Sign In|Join Free
  • or
5-chloro-N-(4-(hydroxymethyl)phenyl)-1H-indole-2-carboxamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

620596-79-4

Post Buying Request

620596-79-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

620596-79-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 620596-79-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,0,5,9 and 6 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 620596-79:
(8*6)+(7*2)+(6*0)+(5*5)+(4*9)+(3*6)+(2*7)+(1*9)=164
164 % 10 = 4
So 620596-79-4 is a valid CAS Registry Number.

620596-79-4Downstream Products

620596-79-4Relevant academic research and scientific papers

Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer Agents

Coluccia, Antonio,La Regina, Giuseppe,Naccarato, Valentina,Nalli, Marianna,Orlando, Viviana,Biagioni, Stefano,De Angelis, Maria Laura,Baiocchi, Marta,Gautier, Candice,Gianni, Stefano,Di Pastena, Fiorella,Di Magno, Laura,Canettieri, Gianluca,Coluccia, Addolorata Maria Luce,Silvestri, Romano

supporting information, p. 499 - 503 (2019/04/25)

Targeted approaches aiming at modulating NHERF1 activity, rather than its overall expression, would be preferred to preserve the normal functions of this versatile protein. We focused our attention on the NHERF1/PDZ1 domain that governs its membrane recruitment/displacement through a transient phosphorylation switch. We herein report the design and synthesis of novel NHERF1 PDZ1 domain inhibitors. These compounds have potential therapeutic value when used in combination with antagonists of β-catenin to augment apoptotic death of colorectal cancer cells refractory to currently available Wnt/β-catenin-targeted agents.

Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a

Onda, Kenichi,Suzuki, Takayuki,Shiraki, Ryota,Yonetoku, Yasuhiro,Negoro, Kenji,Momose, Kazuhiro,Katayama, Naoko,Orita, Masaya,Yamaguchi, Tomohiko,Ohta, Mitsuaki,Tsukamoto, Shin-ichi

, p. 5452 - 5464 (2008/12/21)

A series of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives were prepared and evaluated as inhibitors of human liver glycogen phosphorylase a (hLGPa). One compound, 5-chloro-N-[4-(1,2-dihydroxyethyl)phenyl]-1H-indole-2-carboxamide (2f), inhibited hLGPa with an IC50 of 0.90 μM. The pyridine analogue of 2f showed inhibitory activity of glucagon-induced glucose output in cultured primary hepatocytes with an IC50 of 0.62 μM and oral hypoglycemic activity in diabetic db/db mice. Crystallographic determination of the complex of 2f with hLGPa showed binding of the inhibitor in a solvent cavity at the dimer interface, with the two hydroxyl groups making favorable electrostatic interactions with hLGPa.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 620596-79-4